Incyte
INCY
#1176
Rank
$18.68 B
Marketcap
$95.16
Share price
-1.59%
Change (1 day)
31.97%
Change (1 year)

Incyte (INCY) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : $1.67 Billion USD

According to Incyte's latest financial reports the company's total liabilities are $1.67 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Incyte - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$1.99 B25.4%
2023-12-31$1.59 B8.25%
2022-12-31$1.47 B26.43%
2021-12-31$1.16 B22.5%
2020-12-31$0.94 B14.64%
2019-12-31$0.82 B15.08%
2018-12-31$0.71 B7.12%
2017-12-31$0.67 B-44.88%
2016-12-31$1.21 B45.78%
2015-12-31$0.83 B-4.76%
2014-12-31$0.87 B6.74%
2013-12-31$0.82 B62.78%
2012-12-31$0.50 B-9.11%
2011-12-31$0.55 B-3.84%
2010-12-31$0.57 B-29.03%
2009-12-31$0.81 B79.81%
2008-12-31$0.45 B4.12%
2007-12-31$0.43 B-0.75%
2006-12-31$0.43 B11.44%
2005-12-31$0.39 B-10.24%
2004-12-31$0.43 B94.66%
2003-12-31$0.22 B-9.82%
2002-12-31$0.24 B-5.89%
2001-12-31$0.26 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
$80.52 B 4,695.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$0.52 B-68.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$91.08 B 5,324.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$115.63 B 6,786.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
$0.31 B-81.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
$0.33 B-80.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$62.53 B 3,624.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
$72.38 M-95.69%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
$0.13 B-91.80%๐Ÿ‡บ๐Ÿ‡ธ USA